Connection

ALASTAIR THOMPSON to DNA Methylation

This is a "connection" page, showing publications ALASTAIR THOMPSON has written about DNA Methylation.
Connection Strength

0.213
  1. Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPd) CpG island in breast cancer is associated with metastatic relapse. Br J Cancer. 2012 Aug 07; 107(4):732-8.
    View in: PubMed
    Score: 0.052
  2. NT5E CpG island methylation is a favourable breast cancer biomarker. Br J Cancer. 2012 Jun 26; 107(1):75-83.
    View in: PubMed
    Score: 0.052
  3. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome. Oncogene. 2011 Mar 03; 30(9):1046-58.
    View in: PubMed
    Score: 0.047
  4. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer. Br J Cancer. 2001 Dec 14; 85(12):1878-82.
    View in: PubMed
    Score: 0.025
  5. Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma. J Invest Dermatol. 2013 May; 133(5):1278-85.
    View in: PubMed
    Score: 0.014
  6. NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity. Br J Cancer. 2012 Apr 10; 106(8):1446-52.
    View in: PubMed
    Score: 0.013
  7. The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. Br J Cancer. 2009 May 19; 100(10):1687-96.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.